A New Spectral Shift-Based Method to Characterize Molecular Interactions
ASSAY and Drug Development Technologies · 2022-03 · 20 (2) · 83-94
DOI: 10.1089/adt.2021.133 ↗Kurz gefasst
Fachartikel in der Zeitschrift ASSAY and Drug Development Technologies, online erschienen am 08.03.2022. Verfasst von Andreas Langer und 5 weiteren Autor:innen. Beteiligte Einrichtung: NanoTemper Technologies GmbH, Munich, Germany. Hauptthemen laut MEDLINE: Intrinsically Disordered Proteins. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
There are many fluorescence-based applications that can be used to characterize molecular interactions. However, available methods often depend on site-specific labeling techniques or binding-induced changes in conformation or size of the probed target molecule. To overcome these limitations, we applied a ratiometric dual-emission approach that quantifies ligand-induced spectral shifts with sub-nanometer sensitivity. The use of environment-sensitive near-infrared dyes with the method we describe enables affinity measurements and thermodynamic characterization without the explicit need for site-specific labeling or ligand-induced conformational changes. We demonstrate that in-solution spectral shift measurements enable precise characterization of molecular interactions for a variety of biomolecules, including proteins, antibodies, and nucleic acids. Thereby, the described method is not limited to a subset of molecules since even the most challenging samples of research and drug discovery projects like membrane proteins and intrinsically disordered proteins can be analyzed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NanoTemper Technologies GmbH, Munich, Germany.
- Institute of Neuroimmunology, Slovak Academy of Sciences, Bratislava, Slovakia.
ORCID-Profile: Werner Streicher
Zitieren
APA
Langer, A., Bartoschik, T., Cehlar, O., Duhr, S., Baaske, P., & Streicher, W. (2022). A New Spectral Shift-Based Method to Characterize Molecular Interactions. ASSAY and Drug Development Technologies, 20(2), 83-94. https://doi.org/10.1089/adt.2021.133
Vancouver
Langer A, Bartoschik T, Cehlar O, Duhr S, Baaske P, Streicher W. A New Spectral Shift-Based Method to Characterize Molecular Interactions. ASSAY and Drug Development Technologies. 2022;20(2):83-94. doi:10.1089/adt.2021.133
BibTeX
@article{Langer2022,
author = {Langer, Andreas and Bartoschik, Tanja and Cehlar, Ondrej and Duhr, Stefan and Baaske, Philipp and Streicher, Werner},
title = {A New Spectral Shift-Based Method to Characterize Molecular Interactions},
journal = {ASSAY and Drug Development Technologies},
year = {2022},
volume = {20},
number = {2},
pages = {83--94},
doi = {10.1089/adt.2021.133}
}
EUVIMED